These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35803876)

  • 21. Awareness about vaccine vial monitor at pulse polio booths.
    Chudasama RK
    Indian Pediatr; 2007 Dec; 44(12):919-20. PubMed ID: 18175846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries.
    Kristensen DD; Lorenson T; Bartholomew K; Villadiego S
    Vaccine; 2016 Feb; 34(7):899-904. PubMed ID: 26778422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
    Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
    Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in vaccine stability monitoring technology.
    Zweig SE
    Vaccine; 2006 Aug; 24(33-34):5977-85. PubMed ID: 16759766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody responses of healthy infants to concurrent administration of a bivalent haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines.
    West DJ; Rabalais GP; Watson B; Keyserling HL; Matthews H; Hesley TM
    BioDrugs; 2001; 15(6):413-8. PubMed ID: 11520252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polio endgame: the global introduction of inactivated polio vaccine.
    Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M
    Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions.
    Nelson CM; Wibisono H; Purwanto H; Mansyur I; Moniaga V; Widjaya A
    Bull World Health Organ; 2004 Feb; 82(2):99-105. PubMed ID: 15042231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial.
    Habib MA; Soofi S; Cousens S; Anwar S; Haque NU; Ahmed I; Ali N; Tahir R; Bhutta ZA
    Lancet Glob Health; 2017 Jun; 5(6):e593-e603. PubMed ID: 28495264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine.
    Desai S; Rathi N; Kawade A; Venkatramanan P; Kundu R; Lalwani SK; Dubey AP; Venkateswara Rao J; Narayanappa D; Ghildiyal R; Gogtay NJ; Venugopal P; Palkar S; Munshi R; Bavdekar A; Juvekar S; Ganguly N; Niyogi P; Uttam KG; Kondekar A; Kumbhar D; Mohanlal S; Agarwal MC; Shetty P; Antony K; Gunale B; Dharmadhikari A; Deshpande J; Nalavade U; Sharma D; Bansal A; Tang Y; Flores J; Kulkarni PS
    Vaccine; 2018 Sep; 36(37):5519-5523. PubMed ID: 30104114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polio endgame: the global switch from tOPV to bOPV.
    Garon J; Seib K; Orenstein WA; Ramirez Gonzalez A; Chang Blanc D; Zaffran M; Patel M
    Expert Rev Vaccines; 2016 Jun; 15(6):693-708. PubMed ID: 26751187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunogenicity of oral poliomyelitis vaccine in a primary vaccination series at 2, 4 and 6 months given concurrently with Hib, hepatitis B and diphtheria, tetanus and whole-cell pertussis vaccines administered as three separate injections or as a combination pentavalent vaccine.
    Hogg K; Hogg G
    Vaccine; 2003 Jun; 21(21-22):2906-10. PubMed ID: 12798634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine.
    Kraan H; Ten Have R; van der Maas L; Kersten G; Amorij JP
    Vaccine; 2016 Aug; 34(38):4572-4578. PubMed ID: 27470209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of cool water pack preparation on vaccine vial temperatures in refrigerators.
    Goldwood G; Diesburg S
    Vaccine; 2018 Jan; 36(1):128-133. PubMed ID: 29174313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
    Brickley EB; Strauch CB; Wieland-Alter WF; Connor RI; Lin S; Weiner JA; Ackerman ME; Arita M; Oberste MS; Weldon WC; Sáez-Llorens X; Bandyopadhyay AS; Wright PF
    J Infect Dis; 2018 Jan; 217(3):371-380. PubMed ID: 29304199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A vaccine cold chain temperature monitoring study in the United Mexican States.
    Falcón VC; Porras YVV; Altamirano CMG; Kartoglu U
    Vaccine; 2020 Jul; 38(33):5202-5211. PubMed ID: 32586762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
    Khan MM; Sharma S; Tripathi B; Alvarez FP
    Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature.
    Nedergaard H; Vestergaard S; Jensen PT; Kristiansen MW; Jensen MB; Ostergaard PB; Norsell T; Bjerre J
    Clin Ther; 2008 Jul; 30(7):1309-15. PubMed ID: 18691990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cold chain in a hot climate.
    Guthridge SL; Miller NC
    Aust N Z J Public Health; 1996 Dec; 20(6):657-60. PubMed ID: 9117976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.